NIHSS was used to evaluate the disease severity of AIS patients, and circRNA HECTD1 was shown to be positively correlated with NIHSS score in AIS patients (P < 0.001, r = 0.462, Figure 2). This evidence concerns the gene HECTD1 and androgen insensitivity syndrome.